Close Menu

A functional genomic screen has revealed a new drug combination that boosts the efficacy of KRAS inhibitors for aggressive lung cancer. As reported in Science Translational Medicine, a team led by scientists from the Francis Crick Institute found that a combination of MEK enzyme and IGF1R receptor inhibitors, which shows promise for KRAS-mutant lung cancers in preclinical studies, could be further enhanced by the addition of an mTOR inhibitor.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.